ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985

Bass & Howes Bought By DDB Seattle

March 22, 2002

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002